| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2023 | ARAY Accuray Inc | Chalke Sandeep | SVP, Chief Commercial Officer | Sell | 14,585 | $2.47 | $36,040.99 | -2.6% | +2.4% | -12.2% | |
| Dec 1, 2023 | NPCE Neuropace Inc | Kck Ltd. | 10% Owner | Sell | 16,167 | $8.78 | $141,882.49 | - | +81.7% | +19.1% | |
| Dec 1, 2023 | MXCT Maxcyte, Inc. | Doerfler Douglas81 | President And CEO | Sell | 25,550 | $5.00 | $127,750.00 | -3.7% | -7.6% | -28.7% | |
| Dec 1, 2023 | BLFS Biolife Solutions Inc | Foster Karen A.68 | Chief Quality Officer | Sell | 466 | $12.37 | $5,764.42 | -0.4% | +27.5% | +107.3% | |
| Dec 1, 2023 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 591 | $12.37 | $7,310.67 | -0.2% | +27.5% | +107.3% | |
| Dec 1, 2023 | BLFS Biolife Solutions Inc | Phillips Geraint | SVP, Global Operations | Sell | 303 | $12.37 | $3,748.11 | -0.5% | +27.5% | +107.3% | |
| Dec 1, 2023 | BLFS Biolife Solutions Inc | Wichterman Troy60 | Chief Financial Officer | Sell | 666 | $12.37 | $8,238.42 | -1.0% | +27.5% | +107.3% | |
| Nov 30, 2023 | UFPT Ufp Technologies Inc | Bailly R Jeffrey55 | President And CEO | Sell | 7,496 | $172.54 | $1,293,333.46 | -5.3% | +25.1% | +94.0% | |
| Nov 30, 2023 | PEN Penumbra Inc | O'Rourke Bridget55 | Director | Sell | 150 | $226.41 | $33,961.50 | -3.4% | +3.9% | +9.9% | |
| Nov 30, 2023 | PLSE Pulse Biosciences, Inc. | Duggan Robert W76 | Director, 10% Owner | Buy | 152,944 | $9.06 | $1,385,672.64 | +254.9% | +12.5% | +137.0% | |
| Nov 30, 2023 | STXS Stereotaxis, Inc. | Isaac Paul J78 | Director, See Remarks | Buy | 2,808 | $1.56 | $4,380.48 | +0.1% | +70.3% | +44.8% | |
| Nov 30, 2023 | NSPR Inspiremd, Inc. | Roubin Gary S52 | Director | Buy | 50,000 | $2.53 | $126,540.00 | +12.9% | +19.9% | +27.3% | |
| Nov 30, 2023 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 2,577 | $1.13 | $2,922.83 | - | +15.8% | -45.6% | |
| Nov 30, 2023 | SGHT Sight Sciences, Inc. | Encrantz Staffan74 | Director, 10% Owner | Buy | 144,000 | $3.46 | $497,918.43 | +8.3% | +20.5% | +17.0% | |
| Nov 30, 2023 | STAA Staar Surgical Co | Broadwood Partners, L.P.60 | 10% Owner | Buy | 434,991 | $31.50 | $13,703,830.51 | +0.4% | +0.6% | -7.2% | |
| Nov 29, 2023 | PLSE Pulse Biosciences, Inc. | Duggan Robert W76 | Director, 10% Owner | Buy | 218,600 | $9.38 | $2,049,784.00 | +0.6% | +17.7% | +131.6% | |
| Nov 29, 2023 | TFX Teleflex Inc | Powell Thomas E | Executive Vice President &CFO | Sell | 13,952 | $222.88 | $3,109,671.42 | -15.1% | +2.2% | -12.8% | |
| Nov 29, 2023 | UFPT Ufp Technologies Inc | Bailly R Jeffrey55 | President And CEO | Sell | 1 | $173.00 | $173.00 | - | +19.8% | +87.9% | |
| Nov 29, 2023 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 1,000 | $1.14 | $1,140.00 | - | +12.2% | -46.1% | |
| Nov 29, 2023 | HOLX Hologic Inc | MacMillan Stephen P54 | Chairman, President And CEO | Sell | 47,711 | $70.41 | $3,359,188.38 | -3.7% | +6.7% | +12.6% | |
| Nov 29, 2023 | RXST Rxsight, Inc. | Tammenoms Bakker Juliet | Director | Sell | 494,313 | $29.73 | $14,695,695.32 | -58.6% | +94.5% | +57.4% | |
| Nov 28, 2023 | PLSE Pulse Biosciences, Inc. | Duggan Robert W76 | Director, 10% Owner | Buy | 124,397 | $8.98 | $1,117,085.06 | +0.3% | +13.6% | +133.1% | |
| Nov 28, 2023 | TMDX Transmedics Group, Inc. | Tobin James R60 | Director | Sell | 10,000 | $70.14 | $701,400.00 | -4.1% | +10.6% | +23.9% | |
| Nov 28, 2023 | SYK Stryker Corp | Berry William E Jr | VP, Chief Accounting Officer | Sell | 573 | $292.28 | $167,476.73 | -16.5% | +20.7% | +32.9% | |
| Nov 28, 2023 | BDX Becton Dickinson & Co | Byrd Richard64 | EVP &President Interventional | Sell | 2,156 | $238.47 | $514,141.32 | -34.4% | +2.3% | -4.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.